trending Market Intelligence /marketintelligence/en/news-insights/trending/u39xbrqq78acoun872z3ia2 content esgSubNav
In This List

Dova Pharmaceuticals plans common stock offering

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Dova Pharmaceuticals plans common stock offering

Dova Pharmaceuticals Inc. plans to sell 2.5 million of its common shares in an underwritten public offering.

The company also plans grant the underwriters an option to buy up to an additional 375,000 common shares.

J.P. Morgan Securities LLC, Jefferies LLC and Evercore Group LLC are serving as joint book-running managers for the offering.